Source link : https://newshealth.biz/health-news/weight-loss-drugs-show-promise-but-remain-hard-to-access/
MANCHESTER, England — While evidence mounts to support the widespread use of both semaglutide (Wegovy) and tirzepatide (Mounjaro) in people with heart failure who need to lose weight, experts at the British Cardiovascular Society (BCS) Annual Conference 2025 warned that access to these drugs remains limited in both the UK and the US. Christopher Kramer, […]
The post Weight-Loss Drugs Show Promise but Remain Hard to Access first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-13 09:18:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8